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Research
Growing demand for performance measure-
ment and accountability in public research 
funding has led to a shift in focus for research 
impact assessment (RIA) beyond publications 
to measure accountability of research invest-
ment in broader terms, such as human health 
and environmental improvements as well as 
economic benefits. Conventional bibliomet-
ric analysis, which assesses contributions to 
knowledge, may not be sufficient to assess 
public health impacts.
Recent critiques of approaches to evaluat-
ing government-funded research underscore 
the need for better models and stronger link-
ages between evaluation and decisions about 
funding allocations (Coryn et al. 2007). 
Trochim and colleagues (2008), for example, 
propose an extensive mixed-methods approach 
that draws from diverse data sources to evalu-
ate a large research initiative of the National 
Cancer Institute. A more tightly circumscribed 
approach is reflected in the work of Kuruvilla 
and colleagues (2006), who developed a 
research impact framework to help researchers 
systematically identify impacts resulting from 
their work. The tool also provides a structured 
framework for comparing research impacts 
across projects and time but is limited in that 
it includes data from only one source, the 
researcher. These researchers did not develop a 
full logic model, but rather identified specific 
descriptive categories within four broad areas: 
research-related impacts, policy impacts, ser-
vice impacts, and societal impacts.
Increased interest in documenting 
the public health impacts from publicly 
funded research led the National Institute 
of Environmental Health Sciences (NIEHS) 
Division of Extramural Research (DERT) to 
develop a logic model to measure the impact 
of its extramural grant-funded investments in 
asthma research and to identify indicators to 
monitor changes over time (Figure 1). This 
more specific asthma-related framework was 
derived from work published earlier (Engel-
Cox et al. 2008) to categorize the encompass-
ing range of possible impacts of environmental 
health research related to human health, the 
economy, and environment. Presented here 
is a case study of how new methodologies and 
data sources can move us toward an assess-
ment of public health research impacts, iden-
tifying data structure improvements needed to 
hasten this movement. The types of research 
impacts reported here were those judged to be 
feasible to assess related to the field of asthma. 
Our objective in the present study was to 
apply this conceptual framework in assessing 
the impacts of DERT’s extramural asthma 
research grants funded from 1975 to 2005.
We chose impacts of asthma research 
because of asthma’s public health significance. 
Asthma’s prevalence in the United States has 
nearly doubled since 1970, and it is now the 
most common chronic childhood disease, 
with a prevalence of 8.5% among children in 
2004 (Moorman et al. 2007). In addition to 
morbidity and associated missed school days 
for children, asthma results in missed work 
days for parents, restrictions on physical activ-
ity, and other quality-of-life impairments. It is 
also well documented that persons from low-
income and minority households are dispro-
portionately affected by asthma (Brim et al. 
2008; Persky et al. 2007) and that children 
from these homes are more likely to be treated 
in emergency and urgent care facilities because 
they lack adequate health care   insurance 
  coverage (Inkelas et al. 2008). 
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Ba c k g r o u n d: In the past 15 years, asthma prevalence has increased and is disproportionately 
distributed among children, minorities, and low-income persons. The National Institute of 
Environmental Health Sciences (NIEHS) Division of Extramural Research and Training devel-
oped a framework to measure the scientific and health impacts of its extramural asthma research to 
improve the scientific basis for reducing the health effects of asthma.
oBjectives: Here we apply the framework to characterize the NIEHS asthma portfolio’s impact in 
terms of publications, clinical applications of findings, community interventions, and technology 
developments.
Me t h o d s : A logic model was tailored to inputs, outputs, and outcomes of the NIEHS asthma 
portfolio. Data from existing National Institutes of Health (NIH) databases are used, along with 
publicly available bibliometric data and structured elicitation of expert judgment.
re s u l t s: NIEHS is the third largest source of asthma-related research grant funding within the 
NIH between 1975 and 2005, after the National Heart, Lung, and Blood Institute and the National 
Institute of Allergy and Infectious Diseases. Much of NIEHS-funded asthma research focuses on 
basic research, but results are often published in journals focused on clinical investigation, increas-
ing the likelihood that the work is moved into practice along the “bench to bedside” continuum. 
NIEHS support has led to key breakthroughs in scientific research concerning susceptibility to 
asthma, environmental conditions that heighten asthma symptoms, and cellular mechanisms that 
may be involved in treating asthma.
co n c l u s i o n s: If gaps and limitations in publicly available data receive adequate attention, further 
linkages can be demonstrated between research activities and public health improvements. This 
logic model approach to research impact assessment demonstrates that it is possible to conceptualize 
program components, mine existing databases, and begin to show longer-term impacts of program 
results. The next challenges will be to modify current data structures, improve the linkages among 
relevant databases, incorporate as much electronically available data as possible, and determine how 
to improve the quality and health impact of the science that we support.
key w o r d s : asthma, children, evaluation methodology, health impact analysis, minorities, 
policy, pulmonary organ systems/disease processes, susceptible populations.Environ Health 
Perspect 117:1147–1154 (2009).  doi:10.1289/ehp.0800476 available via http://dx.doi.org/ [Online 
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President Clinton’s 1997 Executive 
Order 13045 required each federal agency 
to identify and evaluate environmental 
health and safety risks that may hinder chil-
dren’s health (Clinton 1997). The directive 
sparked an expansion of research into chil-
dren’s health, including asthma, across the 
National Institutes of Health (NIH), the 
government’s principal agency for research 
that leads to improvements in public health. 
Within the NIH, NIEHS is the third larg-
est source of asthma-related research grant 
funding [after the National Heart, Lung, and 
Blood Institute (NHLBI) and the National 
Institute of Allergy and Infectious Diseases 
(NIAID)]. From fiscal years 1975 to 2005, 
NIEHS awarded approximately $220 mil-
lion in asthma-related grants, compared with 
approximately $1 billion and $324 million at 
NHLBI and NIAID, respectively, during the 
same time period (NIH Electronic Research 
Administration 2009). 
NIEHS supports a multifaceted asthma 
research program, including basic research 
into asthma genetics, respiratory pathogenesis, 
and mechanisms by which particulate matter, 
aerosols, and aeroallergens induce asthmatic 
response; new methods for exposure measure-
ment to dust and airborne allergens associ-
ated with asthma; national surveys to assess 
the risks of exposure to allergens and other 
environmental agents associated with asthma; 
the effectiveness of interventions that lower 
allergen levels in the home; and the effective-
ness of interventions for secondary prevention 
of asthma. 
Approach
In 2006, DERT convened an expert panel 
to review the present state of knowledge 
about measuring the impact of research and 
to inform the development of the aforemen-
tioned conceptual framework that describes 
the agency’s extramural research portfolio 
(Engel-Cox et al. 2008). Panel members were 
selected based on their recognized research 
contributions along the whole bench-to-bed-
side-to-community translational continuum. 
In addition, we refined the conceptual model 
specifically for the asthma research portfo-
lio and conducted a feasibility assessment of 
data sources and potential metrics of interest. 
Expert panel members were also asked to help 
assess the feasibility of accessing different data 
sources in conducting the evaluation and the 
validity of different metrics. We then com-
piled information from those data sources 
identified and developed attribution scenarios 
of how research impacts could be linked to 
the identified grant funding.
The conceptual framework uses a logic 
model format (Kellogg Foundation 2004). 
Components include contextual conditions, 
inputs, research activities, outputs, out-
comes, and ultimate outcomes, with empha-
sis on science, clinical policy and practice, 
environmental policy and practice, and health 
outcomes. We developed indicators for each 
component using publicly available data 
sources (Appendix 1) and a structured elicita-
tion of subject matter experts’ judgment. 
In assessing the public health impacts 
of a research program, the most notice-
able immediate outputs include the use of 
agency-supported research in subsequent 
research, such as citations in the scientific lit-
erature or in follow-up research studies. The 
Scientific Publication Information Retrieval 
and Evaluation System (SPIRES 2007) was 
used to link citations. Other possible imme-
diate outcomes are the use of research in 
influencing the work of commissions, task 
forces, or advisory panels, and the dissem-
ination of interventions beyond the initial 
research study. Potentially effective commu-
nity-based interventions were linked to pub-
lications stemming from NIEHS-funded 
grant research. Appointees to these commit-
tees are often viewed as leaders in the field 
and as having influence on agency or science 
policy and guidelines. Composition of com-
missions, task forces, and agency advisory 
panels was reviewed to determine whether 
NIEHS-sponsored investigators participated. 
Immediate outcomes were assessed through 
bibliometric analysis, content analysis using 
the OmniViz content mapping and visualiza-
tion software (Biowisdom, Inc., Cambridge, 
UK), and other database queries.
Figure 1. Conceptual framework for NIEHS asthma-related research portfolio. ER, emergency department. This logic model lays out inputs, activities, outputs, and 
outcomes of the NIEHS asthma-related research portfolio. Boxes represent types of information collected for the portfolio analysis. Gray text indicates gaps in 
electronically accessible data from which queries can be made and potential areas for future work.
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Intermediate outcomes result as immedi-
ate outcomes become translated into impacts. 
Three main types of impacts include eco-
nomic, environmental, and health and social. 
Economic impacts may include changes in 
technology that affect asthma, such as new 
patents or processes, or new drugs developed. 
We searched the U.S. patent database and 
U.S. Food and Drug Administration (FDA) 
databases of drugs to compile this informa-
tion. Environmental impacts may include 
changes in regulations, policies, or legisla-
tion that eventually result in changes in 
environmental measures, such as outdoor or 
indoor air quality indicators derived from 
U.S. Environmental Protection Agency 
(EPA) databases and U.S. federal legislative 
databases. Finally, health and social changes 
may include changes in guidelines (National 
Guideline Clearinghouse 2009) or health leg-
islation (from U.S. federal and state legisla-
tive databases) that may eventually result in 
behavioral changes for health care provid-
ers, health systems, families, schools, or other 
youth settings. In a preliminary feasibility 
assessment (Liebow et al. 2006), we deter-
mined that regulations, legislation, and for-
mal policy statements rarely cite the evidence 
on which they are based, so that such policy 
instruments cannot be attributed directly to 
specific research projects or centers. Impacts 
that can be more clearly attributed include 
economic impacts such as patents, technology 
changes, and drug development, as well as 
health and social impacts that include guide-
lines and practice changes.
Ultimate outcomes are a combined result 
of changes in intermediate outcomes over 
time and may include decreased asthma mor-
bidity and mortality, incidence of asthma, 
emergency department utilization, decrease 
in hospitalization rates, use of rescue medi-
cines, activity limitations among persons with 
asthma, and decrease in number of school 
or work days missed by persons because of 
asthma. These data were primarily compiled 
from asthma surveillance data available from 
the U.S. Centers for Disease Control and 
Prevention (CDC). 
Results
Results are summarized for each conceptual 
framework element: context, inputs, activities, 
outputs, and outcomes.
Context. Annual congressional appropria-
tions to NIH. Annual appropriations to NIH 
grew steadily from $4.3 billion in 1983 to 
$28.4 billion in 2005 (NIH Office of Budget 
2008). During this same period, the NIEHS 
budget also grew, but at a slower pace, from 
$164.6 million to $720.2 million. The bud-
gets of other NIH institutes and centers grew 
considerably faster, most notably at NIAID 
and NHLBI, growing from $278.9 million 
to nearly $4.3 billion and $624.1 million to 
$2.9 billion, respectively. 
Inputs. Grants and research funding. 
Between 1983 and 2006, DERT spent $218 
million on 161 individual asthma-related 
research grants, adding to a total of 736 grant 
years [the aggregate number of years in which 
all individual principal investigators (PIs) 
affiliated with a specific institution received 
funding from NIEHS] (Table 1). Total extra-
mural funding has increased over time, and 
asthma-related grant awards have risen as a 
percentage of the total extramural portfolio 
over time, climbing to a peak of 9.8% of the 
extramural portfolio in 2003 and dropping to 
7.9% in 2005. The relative share of asthma-
related funding invested in research has also 
increased over time.
Research mechanisms. NIEHS employs 
a range of grant mechanisms to fund asth-
ma-related research. For the purposes of this 
analysis, mechanisms have been grouped into 
four general categories: training grants, inno-
vation research/technology transfer grants, 
center grants (large multiproject grants 
issued to institutions), and research grants 
(Figure 2). Research grants are by far the most 
common type of award found in the asthma 
portfolio, but after 1999 the total funding for 
center grants (which include multiple coordi-
nated projects as well as infrastructure grants) 
exceeds the funding for research grants. The 
number and funding of center grant awards 
fell between 2003 and 2005. The number of 
training grants related to asthma increased in 
the early 2000s, but the funds awarded for 
training grants are much lower, most likely 
because training grants provide only salary 
and tuition for predoctoral and postdoctoral 
trainees and do not support all research-
related expenses. Innovation grants are the 
award type least commonly observed in the 
asthma portfolio. 
Institutional profile. Before 1996, 
the number of grants, PIs, and institutions 
funded were nearly identical. After 1996, 
the number of individuals and institutions 
funded for asthma research from NIEHS 
has mirrored the increases seen in the num-
bers of grants funded, but at lower rates of 
growth [see Supplemental Material, Figure 1 
(available online at http://www.ehponline.
org/members/2009/0800476/suppl.pdf)]. 
Over the 30-year study period, 76 different 
institutions received asthma-related NIEHS 
grants [see Supplemental Material, Table 1 
(available online at http://www.ehponline.
org/members/2009/0800476/suppl.pdf)]. 
Additionally, 63% of the funded institutions 
received funding for just one grant (although 
such grants may have continued over many 
years), and two institutions, Columbia 
University and Johns Hopkins University, 
received more than five unique asthma-related 
grants.
Activities. The annual number and fund-
ing levels of active grants are classified accord-
ing to six general activity categories: basic 
science (e.g., cellular/molecular, genetics); 
organ system/disease process (e.g., respira-
tory); application of technology to disease 
(e.g., Small Business Innovation Research/
Small Business Technology Transfer); center 
grants (e.g., Children’s Environmental Health 
Table 1. NIEHS asthma-related grants compared with total extramural grants, 1983–2005.
  Total no.   Total no.  Total  Total NIEHS  Total
  of NIEHS   of active NIEHS  NIEHS  extramural  extramural
Fiscal  extramural  asthma-related  extramural  asthma-related  asthma-related  
year  grants  grants  funding ($)  funding ($)  (%)
1983  821  4  60,736,000   310,635   0.51
1984  834  4  68,882,000   314,222   0.46
1985  876  1  78,523,000   59,011   0.08
1986  839  4  79,238,000   505,059   0.64
1987  869  5  89,803,000   653,824   0.73
1988  894  3  90,198,000   413,336   0.46
1989  855  3  92,923,000   603,383   0.65
1990  896  2  97,001,000   473,105   0.49
1991  1,000  3  103,996,000   646,597   0.62
1992  929  5  113,469,000   938,711   0.83
1993  909  8  115,708,000   1,447,726   1.25
1994  966  8  129,238,000   1,395,976   1.08
1995  943  10  130,212,000   2,231,820   1.71
1996  1,021  7  139,670,000   1,908,528   1.37
1997  996  16  149,399,000   4,253,311   2.85
1998  1,036  21  159,321,000   4,428,412   2.78
1999  1,072  29  187,196,000   11,526,989   6.16
2000  1,144  81  224,091,000   20,169,948   9.00
2001  1,264  99  318,519,000   26,190,674   8.22
2002  1,308  124  368,815,000   33,802,154   9.17
2003  1,305  96  385,440,000   37,742,742   9.79
2004  1,288  103  383,233,000   37,368,968   9.75
2005  1,237  100  383,925,000   30,476,463   7.94
Total  23,302  736  3,949,536,000  217,861,594  5.51Liebow et al.
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Centers); training (e.g., fellowships); and 
translation (e.g., environmental justice, built 
environment) [see Supplemental Material, 
Figure 2 (available online at http://www.
ehponline.org/members/2009/0800476/
suppl.pdf)]. For both the number of active 
grants and amount of funds awarded over 
time, basic science research has steadily 
increased, with the rate of increase picking 
up beginning in 1998. A rapid increase in 
funds awarded for center grants occurred 
during 1998–2003 and then trailed off after 
2003. Refinements in the activity classifica-
tion scheme would benefit impact assessment, 
because the current categories are not mutu-
ally exclusive (each grant can be classified in 
up to two categories) and center grants often 
encompass multiple projects and centralized 
facility services associated with several types of 
activities either directly or indirectly. 
Outputs. Publications. The NIEHS asth-
ma-related portfolio of 161 unique grants 
has 2,057 asthma-related journal publications 
associated with it (Table 2). Over the 30-year 
study period, the annual rate of publication 
from the asthma portfolio has roughly fol-
lowed the portfolio’s funding profile, with 
a sharp spike in publications emerging after 
1998. During the 1990s, the rate of publica-
tions increased before the dramatic funding 
increase, possibly indicating that preliminary 
studies accumulated to make a compelling 
case for increased research support. As fund-
ing increased dramatically, a time lag is evi-
dent, likely attributable to the time it takes to 
conduct environmental health research and 
publish findings in peer-reviewed literature. 
Even with the expansion of electronic pub-
lishing, most journals currently retain a dual 
print/electronic format, and page limits per-
sist, leaving a time lag. The top 10 journals for 
NIEHS-supported research findings are a mix 
of basic science, clinical, and environmental 
health (Table 3). The total number of publi-
cations by a single PI ranged from 0 to > 100. 
Approximately 25% of PIs with grant awards 
were not associated with any publications, 
whereas approximately 7% of the NIEHS-
supported asthma researchers were associated 
with grants generating > 100 publications. 
Approximately 75% of all the asthma-related 
publications acknowledging NIEHS support 
cited center grant awards.
Asthma-related interventions. A broad 
range of potentially effective community-
based interventions were reported in publica-
tions stemming from NIEHS-funded grant 
research. Highlights of NIEHS-supported 
intervention research include such findings as 
control of asthma in children entails collab-
orative efforts and community-wide environ-
mental control measures (Clark et al. 1999); 
neighborhood asthma coalitions are associated 
with promising reductions in acute care rates 
among active program participants (Fisher 
et al. 2004); and intensive cleaning can pro-
duce significant reductions in cockroach aller-
gen in homes with heavy initial cockroach 
infestations (McConnell et al. 2003).
Overall, evidence of outputs is widely 
available in publicly available data sources 
directly traceable to specific grants. These 
linkages have been possible only recently with 
the development of the SPIRES application 
(developed in large part at NIEHS and now 
available across NIH) that finds peer-reviewed 
articles in the PubMed database (http://www.
ncbi.nlm.nih.gov/sites/entrez?db=pubmed) 
that cite NIH publications. There are some 
limitations in these data, however. Despite 
a recent congressional mandate (NIH 
Reauthorization Act of 2006), grantees do not 
always include grant numbers in publications, 
important journals are not included in the 
PubMed database, and older grant numbers 
are not always unique. These challenges are 
expected to improve over time, and we are 
reasonably confident that the outputs attrib-
utable to the asthma portfolio are representa-
tive of the majority of papers produced. 
Immediate outcomes. Citations. The 
2,057 publications attributed to the NIEHS 
Figure 2. Funding amount (A) and number (B) of NIEHS asthma-related grants by research mechanism, 
1975–2005. Research grants include P01, R01, R03, R15, R18, R21, R24, R25, R29, R33, R37, R55, R56, S (all), 
and U01 mechanisms. Center grants include G12, M01, P (all), U19, U42, and U54 mechanisms. Training 
grants include D (all), F (all), K (all), T (all), U2R, and U45 mechanisms. Innovation, research/technology 
transfer grants include R41, R42, R43, and R44 mechanisms.
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Table 2. Top 10 journals publishing asthma-related research articles funded by NIEHS.
Journals  No. of publications (%)
All NIEHS-funded publications  2,057 (100)
  Environmental Health Perspectives  205 (10)
  American Journal of Respiratory and Critical Care Medicine  74 (4)
  Toxicology and Applied Pharmacology  60 (3)
  Journal of Allergy and Clinical Immunology  51 (2)
  Journal of Biological Chemistry  48 (2)
  American Journal of Respiratory Cell and Molecular Biology  47 (2)
  American Journal of Physiology  41 (2)
  American Journal of Physiology-Lung Cellular and Molecular Physiology  40 (2)
  Journal of Applied Physiology  39 (2)
  Cancer Epidemiology Biomarkers and Prevention  35 (2)Impact of NIEHS Extramural Asthma Research Program
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asthma-related portfolio have been cited a 
total of 29,638 times (1975–2005), with a 
median of 2.1 citations for each publication 
(mean ± SD, 14.1 ± 12.9). About 82% of the 
publications are later cited by other articles. As 
shown in Table 3, the publications that cite 
NIEHS-sponsored work are consistently cited 
in journals with impact factors of 1.9–8.7. 
Of the articles later cited, the average length 
of time until first citation was less than 1 year 
(first cited in the same year published), and 
> 98% of all articles are cited within 3 years.
Publication content. Comparative content 
analysis of asthma-related publications gener-
ated from NIEHS and other agencies revealed 
distinctive patterns relating to the balance 
of clinical and preclinical work, genetic sus-
ceptibility, and environmental influences 
of asthma. These analyses use the OmniViz 
application, which has tools to assess word 
occurrence, distribution, and associations to 
define major discriminating themes and to 
cluster documents with related themes. Such 
themes may be more general (e.g., hyperreac-
tivity) or involve more complex Boolean con-
structs (e.g., hyperreactivity AND eosinophil 
NOT parasites). Publications were clustered 
into areas of similarity by word analysis of 
title and abstract. The results of the cluster 
analysis are visualized for our present pur-
poses in a galaxy diagram (Figure 3) in which 
cluster proximity reflects semantic related-
ness. Fittingly, NIEHS research (indicated in 
yellow) is clustered most heavily in the envi-
ronmental exposure and response mediators 
areas. Another visualization tool, the CoMet 
diagram (OmniViz) (Figure 4) captures a 
global assessment of relationships between 
specific genetic research and sponsoring agen-
cies, providing a graphic way to rapidly focus 
on points of interest. Work since 1996 has 
associated 79 genes with asthma phenotypes, 
seven of which have been associated with 
asthma phenotypes in five or more studies 
(Ober and Hoffjan 2006). NIEHS has funded 
research on genes associated with asthma sus-
ceptibility and has focused funding of genetic 
research on interleukin-4 and interleukin-13, 
two cytokines that, among other things, help 
regulate adaptive immunity to allergens and 
other asthma triggers. This type of visualiza-
tion helps distinguish the various niches for 
each of the funding agencies. 
Role of the environment in asthma 
susceptibility. NIEHS also has a large con-
centration of asthma-related publications 
concerning environmental toxicants on the 
National Priority (Superfund) List (U.S. 
EPA 2008). Research focusing on the chemi-
cals identified as the most hazardous among 
known or threatened releases has significant 
potential for public health improvement. 
Toxicants that are mentioned prominently in 
publications from NIEHS-sponsored research 
include air pollution ingredients (e.g., carbon 
monoxide and other products of combustion; 
polycyclic aromatic hydrocarbons, including 
naphthalene and other benzene compounds), 
environmental tobacco smoke and its con-
stituent ingredients, agricultural chemicals, 
and lipopolysaccharides and other endotoxins.
Commissions, task forces, advisory panels, 
work groups. Development of expertise that 
then informs health policy changes is one pub-
lic health outcome of interest to DERT. The 
2005 membership of various expert groups 
commissioned to assess the need for policy 
change was cross-referenced with the roster 
of NIEHS asthma grant awardees. We identi-
fied multiple FDA and Institute of Medicine 
(IOM) commissions, task forces, advisory pan-
els, and workgroups relevant to asthma. For 
example, recent FDA science advisory panels 
include the Anesthesiology and Respiratory 
Therapy Devices Panel and the Pulmonary-
Allergy Drugs Advisory Committee. For 
IOM, groups examined included current IOM 
members, as well as more specialized groups 
such as the Environmental Health Sciences, 
Research, and Medicine Roundtable. We also 
identified a current advisory panel convened 
by the Joint Commission on the Accreditation 
of Healthcare Organizations (The Joint 
Commission) to recommend asthma-related 
hospital performance measures. In addition, 
we included advisory panels convened to 
develop the two major clinical guidelines for 
asthma care: The Global Initiative for Asthma 
and the National Asthma Education and 
Prevention Program (NAEPP). Ten NIEHS 
agency-funded PIs could be identified as cur-
rent participants in IOM, Joint Commission, 
and NAEPP panels. 
Intermediate outcomes. Economic impacts. 
Asthma can be a disabling chronic disease that 
results in lost work and school days, emergency 
department visits, and other adverse impacts 
with significant financial dimensions. Thus, 
research that leads to improvements in dis-
ease management and reducing the incidence 
of asthma can have substantial long-term 
Figure 3. Asthma-related publications from NIEHS 
and comparison agency-sponsored research. 
Taking the abstracts of all asthma-related publica-
tions resulting from the NIEHS and comparison 
agency grant awards (1975–2005), the OmniViz pro-
gram was used to assess word occurrence, distri-
bution, and associations in the title and abstract of 
each publication to define the major discriminat-
ing themes and to cluster documents with related 
themes. Proximity is a measure of thematic similar-
ity. The closer the papers are, the more similar they 
are. Six clusters emerge, each outlined in a box. 
The blue nodes indicate publications sponsored 
by the comparison agencies, whereas the yellow 
nodes indicate publications sponsored by NIEHS. 
Substantively, NIEHS has concentrated more of 
its efforts in the response mediators and environ-
mental exposures domains.
Response mediators
Muscle mediators
Child, mediators
Clinical reports
Women, pregnancy
Environmental
exposure
Table 3. Top 10 journals containing citations to NIEHS grant-related publications, by citation count, 
research level, and subfield.
  2005 Journal  Journal
Journal (citation count)  impact factor  research levela  Journal subfielda
Environmental Health Perspectives (537)  5.34  Clinical  Clinical medicine/environmental
      investigation    and occupational health
American Journal of Respiratory  8.69  Clinical mix  Clinical medicine/respiratory system
  and Critical Care Medicine (412)     
Toxicological Sciences (302)  3.09  Clinical  Clinical medicine/pharmacology
      investigation 
Toxicology and Applied  3.15  Clinical  Clinical medicine/pharmacology
  Pharmacology (297)      investigation 
American Journal of Physiology–  3.94  Basic  Biomedical research/physiology
  Lung Cellular and Molecular    
  Physiology (291)     
Inhalation Toxicology (269)  1.89  Clinical  Clinical medicine/pharmacology
      investigation
Journal of Biological Chemistry (260)  5.85  Basic  Biomedical research/biochemistry
        and molecular biology
Journal of Allergy and Clinical  7.67  Clinical mix  Clinical medicine/allergy
  Immunology (256)     
American Journal of Respiratory Cell  3.99  Basic  Biomedical research/biochemistry
 a nd Molecular Biology (244)        and molecular biology
European Respiratory Journal (239)  3.95  Clinical mix  Clinical medicine/respiratory system
aData from ipIQ Corporation, 2005. CI/SSCI Journal Classification File, prepared by ipIQ for the National Science 
Foundation under NSF contract SRS0002731, 19 August 2005 (unpublished data). Liebow et al.
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economic payoff. However, there is also an 
intermediate sense in which research funding 
can result in the development of devices and 
disease management techniques that have an 
economic benefit for organizations that have 
development successes. Patents provide one 
concrete, albeit limited, indicator for inter-
mediate economic impacts of research funding.
Research resulting in patents is not 
always traceable to the funding organization 
(Anderson et al. 1996, Narin 1994), because 
the findings may be cited as “prior art” and 
only indirectly attributable to the funding 
organization. A search of the U.S. Patent 
Office online database (all patents since 1790)
and focusing on the Government Interest field 
yielded 66 patents with ES listed as a part of a 
grant number. Of these, four patents (all to 
one PI) matched to a specific NIEHS-funded 
grant. Emerging efforts at NIEHS and NIH 
are working to improve data structures and to 
link patent data with grant funding. 
Technology development. Drug develop-
ment is based on clinical trials research, sup-
ported by basic research in biochemistry and 
pathogenesis, and followed by postmarketing 
surveillance and clinical case reports. Clinical 
trials are often sponsored by pharmaceutical 
companies, although NIH has reaffirmed its 
commitment to support clinical research over 
the past decade (Zerhouni 2003). We searched 
FDA drug approval dockets for publications 
cited that acknowledge NIEHS sponsorship, 
and identified 39 known asthma medications. 
Information about the new drug applications 
for each of the drugs was searched on the FDA 
Web site. Bibliographic references for each 
drug were compiled and then matched against 
the master bibliographic database associated 
with asthma-related grants. NIEHS-sponsored 
research results in publications concerning 
asthma drugs cromolyn, albuterol, epineph-
rine, and fluticasone. Although the associa-
tion is somewhat weak, we were able to link 
NIEHS research to drug research. Many might 
argue whether this is appropriate, as the main 
mission of NIEHS is to study the environ-
mental factors contributing to susceptibility 
rather than to develop therapeutic treatments. 
However, because many of the mechanistic 
processes are related, it is natural that there 
would be at least some overlap.
Additional impacts and attribution dif-
ficulties. Ideally, the NIEHS asthma program 
logic model (Figure 1) would contain direct 
links between intermediate outcomes to addi-
tional impacts such as
•	Environmental	impacts—changes	in	legis-
lation and regulations leading, in turn, to 
improvements in environmental quality.
•	Health	and	social	impacts—changes	in	
health legislation, reductions in asthma mor-
tality, emergency department utilization, 
hospitalization rates, rescue medicine use, 
and improvements in quality of life as indi-
cated by surveillance measures such as the 
CDC’s Behavioral Risk Factor Surveillance 
System, school and work days missed.
Indicators for all of these impacts have 
been included in a monitoring and evaluation 
database that NIEHS has developed for peri-
odic research impact assessment (unpublished 
database). However, in none of these cases 
were we able to link trends to specific research 
activities because either a) it was not feasible to 
collect the data, or b) the data sources available 
had no connection to publications or grants to 
make such a linkage. For example, legislative 
databases often include a legislative history 
and expert testimony in support of legisla-
tion, but in the most optimistic scenario, this 
background information takes the form of 
“research has shown that . . .” without actu-
ally citing any specific researcher’s work. It is 
difficult to obtain information without inter-
viewing individuals about the role of science 
funded by NIEHS in developing legislation 
or regulation. Future assessments will address 
these issues with some of the end users of such 
research, that is, regulators and legislators. 
Limitations
We have assumed from the outset that to be 
transparent and sustainable, periodic evalua-
tions of the research portfolio and its public 
health impacts should be based on indicator 
data that are
•	Readily	accessible	to	NIEHS	staff
•	Consistently	organized	over	the	assessment	
period
•	Electronically	available
•	Documented	with	respect	to	population	
covered, geographic area covered, and inter-
val or frequency of collection.
Through this initial effort we have discov-
ered that indicator data meeting these criteria 
are generally available to support conventional 
bibliometric analyses of research publications. 
Certain limitations apply, however. Beyond 
publications, indicators of other activities, 
outputs, and outcomes are not as well sup-
ported. Refinements to current data struc-
tures within the agency, such as estimating 
the portion of a given center grant related 
to a disease, condition, or health end point, 
would assist with public health impact assess-
ments. Conference papers and presentations, 
often a channel for early release of findings, 
rarely include publicly available information 
about funding sources. Commission/taskforce 
membership is difficult to cross-reference with 
grant recipients because there are no cen-
tral repositories of active group rosters for 
comparison with author lists. In addition, 
although current members of such groups are 
often listed on agency Web sites, past com-
mission/task force membership lists are not 
easily available. Thus, it is difficult to know 
whether agency-sponsored PIs participated in 
such activities in the past. Legislation, which 
can have a profound impact on public health, 
almost never cites research findings that may 
Figure 4. Distribution of genes of interest across grants, by agency. This CoMet visualization highlights 
the specific genetic foci (columns) associated with each agency’s asthma-related research portfolio 
(rows). The warmer the color (i.e., yellow, orange, and red), the greater the number of grants awarded for 
research on a particular genetic location or complex. The cooler the color (green, blue, purple), the fewer 
the number of grants awarded for a particular genetic location or complex. This visualization shows the 
varied agency interests in specific genes, indicating unique niches and areas of overlap. NIEHS, although 
not awarding as many grants as its NHLBI and NIAID counterparts, is focusing its resources in a manner 
mostly consistent with these two institutes. A gene that is hot in NIEHS-supported grants but studied at 
only one other institute is glutathione S-transferase, an oxidative stress gene often associated with envi-
ronmental exposures such as ozone. 
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well be what has prompted the legal interven-
tion. Additional work is underway to sur-
vey asthma researchers funded by NIEHS 
(1975–2005) and likely end users of this 
research to obtain their views on dissemina-
tion channels most likely to have policy and 
public health impacts.
Additionally, grant data available in the 
Information for Management, Planning, 
Analysis, and Coordination (IMPAC II) data-
base at the time of this analysis were restricted 
to title and abstract, thus limiting the extent 
of information that could be extracted. For 
example, additional information about asso-
ciated genes is likely available in the “spe-
cific aims” sections of grant applications but 
until recently were not searchable. Similarly, 
annual progress reports, which are not search-
able within the IMPAC II database, contain 
a wealth of information about the actual 
research conducted (not just the proposed 
research) and about results and outcomes that 
may not be publishable findings and thus 
might not emerge in a bibliometric analysis. 
The ultimate outcome measures, represent-
ing indicators of decreased asthma morbidity 
and mortality, are also limited. Ultimate out-
comes take the longest time to realize and may 
not be observed for ≥ 10 years after research 
findings are first reported. Although ultimate 
outcome measures should be included in our 
long-term assessments of scientific and public 
health impacts, they are the least direct of all, 
and attribution to a particular research project 
or program will likely never be definitive.
Conclusions 
Although conventional bibliometric methods 
can be useful to understand improvements in 
knowledge relating to public health advances, 
these methods alone are insufficient to assess 
the broad range of contributions made pos-
sible by research funding. Instead, using a 
conceptual framework and reviewing a broad 
variety of existing electronic databases can help 
to shed additional light on the types of out-
comes that are possible and salient for assessing 
research impact. NIEHS has taken a signifi-
cant step toward implementing a framework 
that helps us think globally about specific 
mechanisms by which research investments 
contribute to public health improvements. 
Although the nature of scientific discovery is 
well enough infused with contingency and ser-
endipity to thwart any effort to achieve defini-
tive attribution of public health improvements 
to a specific research grant award, a portfolio 
analysis like the one presented here clearly 
points to more immediate outcomes that, in 
the aggregate, become the necessary and suf-
ficient conditions under which such public 
health improvements are achieved.
The call for increased transparency and 
accountability in federal science policy 
requires that we think strategically about mod-
ifications to current data structures that allow 
us to track expenditures and research results 
over time. Improved linkages between rel-
evant databases (such as searchable patent and 
investigational new drug applications with the 
federal grant database) will assist with attribu-
tion of near-term and intermediate outcomes 
to research funding. Improved data structures 
and the ability to search progress reports and 
Appendix 1. Summary of data sources for Asthma Portfolio Research Impact Assessment.
Data category  Sources
Input indicators
NIH budget data    NIH Office of the Budget (http://officeofbudget.od.nih.gov/UI/history.htm)
NIH asthma-related budget data    IMPAC II
    NIEHS internal analysis of NIEHS center grants
Non-NIH agency budget data     IMPAC II [http://era.nih.gov/impacii/index.cfm (for authorized users only)] 
Activity indicators
Grant awards, institutions, PIs    IMPAC II
    U.S. EPA, National Center for Environmental Research 
    (http://es.epa.gov/ncer/grants/)
Output indicators
Publications    SPIRES
    PubMed (www.pubmed.gov)
    U.S. EPA (http://es.epa.gov/ncer/grants/)
Curricula, interventions, and    NIEHS (http://www-apps.niehs.nih.gov/outreach-education/)
  outreach materials    U.S. EPA (http://www.epa.gov/iaq/schools/asthma/) 
    (http://www.epa.gov/asthma/) 
    (http://www.epa.gov/asthma/community.html)
    (http://www.epa.gov/asthma/publications.html)
    CDC (http://www.cdc.gov/asthma/links.htm) 
    (http://www.cdc.gov/asthma/default.htm)
    NHLBI (http://www.nhlbi.nih.gov/health/public/lung/index.htm#asthma)
    NAEPP (http://www.nhlbi.nih.gov/about/naepp/index.htm)
    ATSDR (http://www.atsdr.cdc.gov/HEC/CSEM/asthma/index.html)
    NIOSH (http://www.cdc.gov/niosh/topics/asthma/#prevention)
    NIAID (http://www.niaid.nih.gov/publications/asthma.htm)
    NLM (http://www.nlm.nih.gov/medlineplus/asthmainchildren.html)
    American Lung Association 
    (http://www.lungusa.org/site/pp.asp?c=dvLUK9O0E&b=22542)
    American Academy of Allergy, Asthma and Immunology 
    (http://www.aaaai.org/)
    CDC Asthma Intervention Database 
    (http://www.cdc.gov/asthma/interventions/default.htm)
Outcome indicators
Citation database    Thompson Scientific Institute for Scientific Information Science Citation index 
    and journal citation reports 
    (http://www.thomsonreuters.com/products_services/scientific/Journal_ 
    Citation_Reports)
Commissions, task forces,     Institute of Medicine (http://www.iom.edu/)
  advisory panels, work groups    FDA science advisory panels 
    Agency for Healthcare Research and Quality (http://guidelines.gov)
Patents    U.S. Patent Database (www.uspto.gov/patft/index.html)
Drugs    FDA’s Center for Drug Evaluation and Research (CDER)
    (http://www.accessdata.fda.gov/scripts/cder/drugsatfda/)
Legislation    Federal (http://thomas.loc.gov) 
    State–National Conference of State Legislatures: 
    Asthma-Related State Legislation and Statutes Database 
    (http://www.ncsl.org/default.aspx?tabid=17322)
    Air Quality Policy Database
    (http://www.ncsl.org/programs/environ/air/airqualitydb.cfm)
Guidelines and care standards     National Guidelines Clearinghouse Database (http://www.guidelines.gov/)
Environmental changes related    U.S. EPA Air Quality System Database
 to air quality      (http://www.epa.gov/air/data/aqsdb.html)
Asthma mortality    National Center for Health Statistics National Vital Statistics System 
    (http://www.cdc.gov/mmwr/preview/mmwrhtml/00052262.htm#00003083.htm)
Emergency department utilization    National Center for Health Statistics National Ambulatory Medical Care Survey
    (http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5101a1.htm)
Hospitalization    National Ambulatory Medical Care Survey 
    (http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5101a1.htm)
Rescue medicine use     CDC’s National Asthma Survey
    (http://www.cdc.gov/nchs/about/major/slaits/nas.htm) 
Quality of life indicators    CDC’s Behavioral Risk Factor Surveillance System
    National Center for Health Statistics National Health Interview Survey 
    (http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5101a1.htm#tab3)Liebow et al.
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specific aims side by side with grant titles and 
abstracts will increase access to scientific out-
put data useful for impact assessment. As the 
use of publication data increases, grantees will 
become even more aware of the importance 
of acknowledging grant support, creating a 
more complete picture of the publication 
products of the extramural research portfolio. 
This in turn may increase the likelihood that 
grant support will be properly acknowledged 
in publications and downstream clinical and 
public health applications.
Making sense of the vast and highly seg-
mented landscape of research reports and pub-
lications produced with public grant support 
is a challenge, but new content analysis tools, 
coupled with visualization techniques, show 
great promise in taking documents in diverse 
formats to highlight patterns over time and 
across narrowly defined subspecialty areas.
NIEHS efforts reported here and in the 
companion article by Engel-Cox et al. (2008) 
demonstrate that it is possible to conceptual-
ize program components, mine existing data-
bases, and begin to show longer-term impacts 
of program results. The next challenges will 
be to modify current data structures, improve 
the linkages among relevant databases, and 
determine how to improve the science that 
we support. DERT’s charge is to distribute 
resources in ways that produce the best science 
to achieve a healthier population. We can now 
begin to ask questions such as: How should 
DERT structure its funding portfolio to create 
the best chances to produce innovation? How 
should investigators be made aware of ways 
in which their work can inform policies and 
environmental management regimes that, in 
turn, lead to public health improvements? To 
create interdisciplinary synergies, what is the 
ideal portfolio blend of institutional depth and 
breadth of research investments? We cannot 
answer these questions now, but the frame-
work allows us to sharpen the focus of our 
thinking about how to structure information 
to answer these questions in the future.
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